The EMA has extended the indications for Darzalex (daratumumab) to the treatment of adults at high risk of developing ...

The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...

The European Union's medicine regulator has begun a review of some medicines that contain sodium oxybate and are used to treat alcohol withdrawal syndrome, it said on Friday. Sodium oxybate is an ...

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

The European Medicines Agency’s human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines at its June meeting.

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

Johnson & Johnson (NYSE:JNJ) said that an advisory committee of the EU drug regulator, the European Medicines Agency (EMA), ...

Madrigal Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Rezdiffra treatment for adults with the liver disease ...

AbbVie said on Wednesday its migraine drug met the main goal and was superior to a widely used generic treatment in a head-to ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.